Concepts (156)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
| Papillomavirus Vaccines | 6 | 2019 | 405 | 1.89 | Why? |
| Denmark | 21 | 2021 | 2654 | 1.17 | Why? |
| Fluorocarbons | 1 | 2020 | 102 | 0.80 | Why? |
| Papillomavirus Infections | 5 | 2019 | 861 | 0.66 | Why? |
| Mink | 1 | 2021 | 399 | 0.66 | Why? |
| Adverse Drug Reaction Reporting Systems | 2 | 2019 | 694 | 0.64 | Why? |
| Environmental Pollutants | 1 | 2020 | 320 | 0.60 | Why? |
| Mortality | 5 | 2021 | 7132 | 0.60 | Why? |
| Influenza, Human | 5 | 2021 | 10779 | 0.56 | Why? |
| Cause of Death | 5 | 2021 | 4823 | 0.55 | Why? |
| Animals, Wild | 1 | 2021 | 1028 | 0.50 | Why? |
| Child Day Care Centers | 1 | 2015 | 208 | 0.49 | Why? |
| Registries | 9 | 2021 | 12327 | 0.49 | Why? |
| Biological Specimen Banks | 1 | 2020 | 1142 | 0.49 | Why? |
| Disease Reservoirs | 2 | 2021 | 1672 | 0.48 | Why? |
| Vaccination | 8 | 2019 | 19050 | 0.48 | Why? |
| Shiga-Toxigenic Escherichia coli | 1 | 2009 | 7 | 0.41 | Why? |
| Gastroenteritis | 1 | 2015 | 489 | 0.41 | Why? |
| Environmental Exposure | 1 | 2020 | 1558 | 0.40 | Why? |
| Mass Media | 1 | 2018 | 837 | 0.40 | Why? |
| Meat Products | 1 | 2009 | 39 | 0.39 | Why? |
| Bacteremia | 1 | 2017 | 1372 | 0.30 | Why? |
| Foodborne Diseases | 2 | 2018 | 89 | 0.29 | Why? |
| Escherichia coli Infections | 1 | 2009 | 348 | 0.29 | Why? |
| Child, Preschool | 15 | 2021 | 36283 | 0.28 | Why? |
| Infant | 13 | 2021 | 30274 | 0.28 | Why? |
| Seasons | 1 | 2017 | 4071 | 0.27 | Why? |
| Disease Outbreaks | 5 | 2021 | 27595 | 0.26 | Why? |
| Infant, Newborn | 9 | 2021 | 23105 | 0.25 | Why? |
| Child | 17 | 2021 | 70012 | 0.25 | Why? |
| Coronavirus | 2 | 2020 | 18339 | 0.21 | Why? |
| Models, Statistical | 1 | 2018 | 5312 | 0.21 | Why? |
| Complex Regional Pain Syndromes | 1 | 2019 | 7 | 0.20 | Why? |
| Orthostatic Intolerance | 1 | 2019 | 23 | 0.20 | Why? |
| Public Health | 3 | 2021 | 16359 | 0.20 | Why? |
| Sentinel Surveillance | 2 | 2017 | 1093 | 0.19 | Why? |
| Computer Systems | 1 | 2021 | 255 | 0.19 | Why? |
| Farms | 1 | 2021 | 269 | 0.19 | Why? |
| Adolescent | 15 | 2021 | 86841 | 0.19 | Why? |
| Postural Orthostatic Tachycardia Syndrome | 1 | 2019 | 52 | 0.19 | Why? |
| Intracranial Arterial Diseases | 1 | 2017 | 9 | 0.18 | Why? |
| Preliminary Data | 1 | 2020 | 457 | 0.18 | Why? |
| Europe | 3 | 2021 | 12702 | 0.18 | Why? |
| Disease Transmission, Infectious | 1 | 2021 | 9044 | 0.17 | Why? |
| Heptavalent Pneumococcal Conjugate Vaccine | 1 | 2017 | 64 | 0.17 | Why? |
| Growth Disorders | 1 | 2017 | 91 | 0.16 | Why? |
| Reminder Systems | 1 | 2017 | 104 | 0.16 | Why? |
| Young Adult | 11 | 2021 | 93724 | 0.16 | Why? |
| Polymerase Chain Reaction | 2 | 2021 | 6740 | 0.15 | Why? |
| Cross Infection | 2 | 2019 | 8675 | 0.15 | Why? |
| Vaccines, Conjugate | 1 | 2017 | 328 | 0.14 | Why? |
| Genes, Viral | 1 | 2021 | 1428 | 0.14 | Why? |
| Public Health Surveillance | 2 | 2019 | 3129 | 0.14 | Why? |
| Chickenpox | 1 | 2017 | 194 | 0.14 | Why? |
| Population Surveillance | 2 | 2020 | 4967 | 0.13 | Why? |
| Adult | 15 | 2021 | 244371 | 0.12 | Why? |
| Whole Genome Sequencing | 2 | 2021 | 3239 | 0.12 | Why? |
| Poland | 1 | 2021 | 2368 | 0.12 | Why? |
| Environment | 1 | 2019 | 769 | 0.12 | Why? |
| Humans | 33 | 2021 | 930598 | 0.12 | Why? |
| Cohort Studies | 8 | 2021 | 36005 | 0.12 | Why? |
| Severity of Illness Index | 1 | 2020 | 48226 | 0.12 | Why? |
| Streptococcus pneumoniae | 1 | 2017 | 827 | 0.12 | Why? |
| Female | 17 | 2021 | 380317 | 0.11 | Why? |
| Hospitalization | 3 | 2021 | 54280 | 0.11 | Why? |
| Pneumococcal Vaccines | 1 | 2017 | 571 | 0.11 | Why? |
| History, 21st Century | 1 | 2019 | 1849 | 0.11 | Why? |
| Datasets as Topic | 1 | 2018 | 1404 | 0.11 | Why? |
| Middle Aged | 14 | 2021 | 270681 | 0.11 | Why? |
| Pneumococcal Infections | 1 | 2017 | 562 | 0.11 | Why? |
| Aged | 11 | 2021 | 215776 | 0.11 | Why? |
| Meningococcal Infections | 1 | 2014 | 216 | 0.11 | Why? |
| Male | 16 | 2021 | 367725 | 0.11 | Why? |
| Blood Donors | 2 | 2021 | 2956 | 0.10 | Why? |
| Age Distribution | 1 | 2020 | 3567 | 0.10 | Why? |
| Immunization Programs | 3 | 2018 | 2006 | 0.10 | Why? |
| Bacterial Infections | 1 | 2004 | 2229 | 0.10 | Why? |
| Urban Population | 1 | 2020 | 2000 | 0.10 | Why? |
| Vaccination Refusal | 1 | 2018 | 831 | 0.10 | Why? |
| Surgery Department, Hospital | 1 | 2019 | 954 | 0.10 | Why? |
| Incidence | 4 | 2021 | 25622 | 0.10 | Why? |
| Sex Distribution | 1 | 2017 | 2083 | 0.10 | Why? |
| Patient Acceptance of Health Care | 2 | 2018 | 5002 | 0.10 | Why? |
| Databases, Factual | 3 | 2021 | 6248 | 0.09 | Why? |
| Drug-Related Side Effects and Adverse Reactions | 1 | 2019 | 1261 | 0.09 | Why? |
| Databases as Topic | 1 | 2009 | 103 | 0.09 | Why? |
| Gastrointestinal Diseases | 1 | 2004 | 2580 | 0.09 | Why? |
| Aged, 80 and over | 4 | 2021 | 88759 | 0.09 | Why? |
| Program Evaluation | 1 | 2017 | 1929 | 0.09 | Why? |
| Commerce | 1 | 2018 | 1109 | 0.09 | Why? |
| Headache | 1 | 2019 | 2257 | 0.09 | Why? |
| Food Microbiology | 1 | 2009 | 114 | 0.09 | Why? |
| Epidemiological Monitoring | 1 | 2021 | 3493 | 0.09 | Why? |
| Zoonoses | 1 | 2021 | 3034 | 0.08 | Why? |
| Qualitative Research | 1 | 2019 | 4337 | 0.08 | Why? |
| Anti-Bacterial Agents | 2 | 2019 | 10083 | 0.08 | Why? |
| Child Health | 1 | 2015 | 940 | 0.07 | Why? |
| Health Resources | 1 | 2019 | 2592 | 0.07 | Why? |
| Case-Control Studies | 2 | 2018 | 17671 | 0.07 | Why? |
| Survival Analysis | 1 | 2018 | 7592 | 0.07 | Why? |
| Parents | 1 | 2018 | 2758 | 0.07 | Why? |
| Autoimmune Diseases | 1 | 2018 | 1996 | 0.07 | Why? |
| Computer Simulation | 1 | 2017 | 4982 | 0.06 | Why? |
| Proportional Hazards Models | 1 | 2015 | 6543 | 0.06 | Why? |
| Brain Ischemia | 1 | 2017 | 2813 | 0.06 | Why? |
| Pneumonia, Viral | 2 | 2020 | 243684 | 0.06 | Why? |
| Coronavirus Infections | 2 | 2020 | 253789 | 0.06 | Why? |
| Electronics | 1 | 2021 | 199 | 0.05 | Why? |
| Smoking | 1 | 2014 | 3358 | 0.05 | Why? |
| Pandemics | 4 | 2021 | 389249 | 0.05 | Why? |
| Algorithms | 1 | 2017 | 7346 | 0.05 | Why? |
| Severe Acute Respiratory Syndrome | 1 | 2003 | 12361 | 0.05 | Why? |
| Venous Thromboembolism | 1 | 2018 | 4273 | 0.05 | Why? |
| Nervous System Diseases | 1 | 2018 | 4092 | 0.05 | Why? |
| Influenza A virus | 1 | 2011 | 2234 | 0.05 | Why? |
| Health Care Sector | 1 | 2021 | 191 | 0.05 | Why? |
| Age Factors | 2 | 2020 | 21039 | 0.04 | Why? |
| Mali | 1 | 2017 | 181 | 0.04 | Why? |
| Prevalence | 2 | 2017 | 25773 | 0.04 | Why? |
| Hospitals | 1 | 2017 | 11793 | 0.04 | Why? |
| Poisson Distribution | 1 | 2018 | 348 | 0.04 | Why? |
| RNA, Viral | 2 | 2021 | 32276 | 0.04 | Why? |
| Ghana | 1 | 2019 | 763 | 0.04 | Why? |
| Regression Analysis | 1 | 2004 | 2484 | 0.04 | Why? |
| Antibiotic Prophylaxis | 1 | 2019 | 399 | 0.04 | Why? |
| Risk Factors | 4 | 2020 | 71621 | 0.04 | Why? |
| Sensitivity and Specificity | 1 | 2017 | 22971 | 0.04 | Why? |
| Seroepidemiologic Studies | 2 | 2021 | 10017 | 0.04 | Why? |
| Animals | 2 | 2021 | 78931 | 0.04 | Why? |
| Logistic Models | 1 | 2009 | 9089 | 0.03 | Why? |
| Comorbidity | 3 | 2021 | 34796 | 0.03 | Why? |
| Cluster Analysis | 1 | 2019 | 3001 | 0.03 | Why? |
| Norway | 1 | 2014 | 1004 | 0.02 | Why? |
| Patient Isolation | 1 | 2003 | 3182 | 0.02 | Why? |
| Immunization | 1 | 2019 | 2019 | 0.02 | Why? |
| Basic Reproduction Number | 1 | 2021 | 2676 | 0.02 | Why? |
| History, 19th Century | 1 | 2011 | 384 | 0.02 | Why? |
| Health Care Surveys | 1 | 2019 | 2942 | 0.02 | Why? |
| Sweden | 1 | 2014 | 1969 | 0.02 | Why? |
| Betacoronavirus | 2 | 2020 | 204454 | 0.02 | Why? |
| Chronic Disease | 1 | 2020 | 5139 | 0.02 | Why? |
| Odds Ratio | 1 | 2017 | 5861 | 0.02 | Why? |
| Risk Assessment | 2 | 2021 | 25439 | 0.02 | Why? |
| History, 20th Century | 1 | 2011 | 1282 | 0.02 | Why? |
| Netherlands | 1 | 2014 | 3533 | 0.02 | Why? |
| Cross-Sectional Studies | 2 | 2021 | 53120 | 0.02 | Why? |
| Congresses as Topic | 1 | 2011 | 1347 | 0.01 | Why? |
| Surveys and Questionnaires | 1 | 2009 | 43792 | 0.01 | Why? |
| Retrospective Studies | 3 | 2019 | 105322 | 0.01 | Why? |
| Global Health | 1 | 2003 | 13911 | 0.01 | Why? |
| Genome, Viral | 1 | 2021 | 13157 | 0.01 | Why? |
| Antibodies, Viral | 2 | 2021 | 51949 | 0.01 | Why? |
| Follow-Up Studies | 1 | 2017 | 17020 | 0.01 | Why? |
| Longitudinal Studies | 1 | 2014 | 9893 | 0.01 | Why? |
| Respiratory Tract Infections | 1 | 2017 | 6817 | 0.01 | Why? |
| Communicable Disease Control | 1 | 2003 | 29620 | 0.01 | Why? |
Mølbak's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts
(156)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(190)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_